← Leaderboards
Duane Ellington Day
Molecular Innovations, Inc.
$1,190,526
Attributed
$1,190,526
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $116.8K · FY2008–10$200K$150K$100K$50K$0
'08
'09
'10
Funding mix
By agency
NIH$1,190,526 · 4
By mechanism
R44$861,742 · 1
R43$328,784 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Protease Inhibitor”
- Constance Ann Benson · University Of California, San Diego$150,461,206
- Robert Turner Schooley · University Of Colorado Denver$48,400,257
- John Damon Chodera · Sloan-Kettering Inst Can Research$40,777,114
- Daniel R Kuritzkes · Brigham And Women'S Hospital$26,572,064
- David Heimbrook · Leidos Biomedical Research, Inc.$26,054,235
- Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester$24,364,826
Research focus
Protease InhibitorProtein EngineeringCathepsin GSite Directed MutagenesisNeutrophilPlasminogen Activator InhibitorsGene MutationElastasesBaseMutantNonhuman Therapy EvaluationLaboratory MouseInnovationLung DisorderBiologicalEscherichia ColiDrug Discovery /IsolationDisease /Disorder ModelBiotechnologyDrug Screening /EvaluationDesignLaboratoriesFermentationMethodology
Grant awards (5)
A rapid, sensitive assay for quantitation of human prorenin in biological samples$112,349
R43 · FY2010 · DK · contact PI
High level expression and purification of therapeutic human and mouse neuroserpin$116,835
R43 · FY2008 · NS · contact PI
Novel PA1-Inhibitors of Neutrophil Proteinases$424,685
R44 · FY2004 · HL
Novel PA1-Inhibitors of Neutrophil Proteinases$437,057
R44 · FY2003 · HL
Novel PAI-1 Inhibitors of Neutrophil Proteinases$99,600
R43 · FY2002 · HL